Futureheal Inc utilizes AI-driven diagnostic decision support systems to provide personalized assessments for congenital anomalies and appendicitis in pediatric patients. This technology enhances diagnostic accuracy and streamlines the healthcare process, reducing the need for patients to navigate multiple healthcare providers.
Funding
Funding not disclosed
Founders
Product
Problem
Diagnosing congenital anomalies and appendicitis in pediatric patients often involves navigating multiple healthcare providers and can be subject to diagnostic inaccuracies. This can lead to delays in treatment and increased stress for patients and their families.
Solution
Futureheal provides AI-driven diagnostic decision support systems designed to deliver personalized assessments for congenital anomalies (Fetalist) and appendicitis (Appai) in pediatric patients. These systems aim to enhance diagnostic accuracy by providing clinicians with a definitive diagnosis, potentially reducing the need for patients to consult with multiple specialists. By streamlining the diagnostic process, Futureheal seeks to improve patient outcomes and reduce the burden on healthcare systems. The platform offers benefits to patients by providing quicker and more accurate diagnoses, to doctors by offering legal safety and definitive diagnostic support, to hospitals by improving customer loyalty, and to imaging companies by improving customer loyalty.
Target Audience
Futureheal's primary target audience includes pediatric patients, doctors, hospitals, and imaging companies seeking to improve diagnostic accuracy and streamline the healthcare process for congenital anomalies and appendicitis.
Features
- **Fetalist:** AI-based diagnostic decision support for congenital anomalies.
- **Appai:** AI-based diagnostic decision support for appendicitis.
- Personalized diagnostic assessments.
- Aims to provide a definitive diagnosis to clinicians.